@anunciamedical

User Guide Video: The ReFlow Mini Flusher

WEBINAR: First Clinical Experience of the ReFlow Mini Flusher - Presented 10/20/2023

WEBINAR: ReFlow Mini Flusher, A Patient & Neurosurgeon Perspective

Patient Brochure Download

Clinician Flier Download

A Noninvasive Retrograde Flushing System for Shunted Hydrocephalus: Initial Case Series of 25 Patients

In situ clearance of a proximal shunt malfunction in a child with hydrocephalus post cerebral arteriovenous malformation rupture noted intraoperatively - PubMed

Our Website

Facebook

LinkedIn

Instagram

YouTube

Anuncia Medical Receives FDA Breakthrough Device Designation for ReFlow® External Ventricular Drains (EVD)

Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow™ Mini Flusher Device for Hydrocephalus Patients - Anuncia

7-year-old Boy Managing His Hydrocephalus with ReFlow™ Ventricular System “Gen 1” Featured on Charleston’s ABC News 4 - Anuncia

Anuncia Medical Successfully Launches Second Generation Device to Treat Hydrocephalus at Several Leading Neurosurgical Centers Across the United States - Anuncia

Anuncia Medical Announces First Successful US Implant of the Company’s ReFlow™ Device with Sonolucent Cranial Plate to Noninvasively Visualize Flushing of Hydrocephalus Shunts - Anuncia

Anuncia Medical, Inc., Announces Published Data with Clinical Outcomes Using the ReFlow™ Ventricular System In-Line with Hydrocephalus Shunts | Hydrocephalus Association

Anuncia Medical, Inc., receives FDA clearance for the ReFlow® System Mini for the treatment of patients with hydrocephalus

Update on Anuncia ReFlow System Mini for Hydrocephalus

Anuncia Inc. Receives FDA "Breakthrough Device Designation" for ReFlow™ System Mini

Anuncia Medical’s ReFlow System Mini Cleared

Anuncia Medical, Inc. Honored with an AZBio Fast Lane Award

Anuncia Medical honored as participant in the 2022 Flinn Foundation Bioscience Entrepreneurship Program

Seven Arizona bioscience startups to watch in 2022

Medtech company Anuncia announces relocation to Scottsdale

Anuncia Announces Successful First-in-Human Use of the Alivio ReFlow™ Ventricular System for Treatment of Hydrocephalus | BioSpace

'Ponte Cura' Celebrates the Conclusion of AZ Bioscience Week 2022 - Held at Anuncia's CEO's House

Anuncia Medical Inc. Announces Published Data with Promising Clinical Outcomes Using the ReFlow™ Ventricular System In-Line with Hydrocephalus Shunts – Anuncia